Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis ... - PR Newswire (press release) PDF Print
PR Newswire (press release)23 /PRNewswire/ -- Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.